Alzheimer's disease: Are non-steroidal anti-inflammatory drugs effective?

被引：0
|
作者：
Peters, Oliver [1 ]
机构：
[1] Charite, Klin Psychiat & Psychotherapie, Berlin, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2012年 / 137卷 / 50期
关键词：
D O I：
10.1055/s-0032-1329138
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2627 / 2627
页数：1
相关论文
共 50 条
  • [11] NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    JACOBELLI, S
    REVISTA MEDICA DE CHILE, 1978, 106 (11) : 923 - 931
  • [12] NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    不详
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1966, 94 (07) : 358 - +
  • [13] NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    OBRIEN, WM
    PHARMACOLOGY, 1982, 25 : 1 - 8
  • [14] NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    MARKS, BE
    JOURNAL OF THE ROYAL COLLEGE OF GENERAL PRACTITIONERS, 1988, 38 (310): : 229 - 229
  • [15] NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    MILLER, RR
    NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (15): : 883 - 883
  • [16] NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    TOMPKINS, RB
    MINNESOTA MEDICINE, 1979, 62 (09) : 677 - 678
  • [17] Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation
    Moore, Amy H.
    Bigbee, Matthew J.
    Boynton, Grace E.
    Wakeham, Colin M.
    Rosenheim, Hilary M.
    Staral, Christopher J.
    Morrissey, James L.
    Hund, Amanda K.
    PHARMACEUTICALS, 2010, 3 (06): : 1812 - 1841
  • [18] NON-STEROIDAL ANTI-INFLAMMATORY DRUGS .3. SIDE-EFFECTS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    BROOKS, PM
    MEDICAL JOURNAL OF AUSTRALIA, 1988, 148 (05) : 249 - 251
  • [19] NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) Use of non-steroidal anti-inflammatory drugs (NSAIDs) as immunomodulatory agents
    Fullerton, James N.
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
  • [20] Soothing the Inflamed Brain: Effect of Non-Steroidal Anti-Inflammatory Drugs on Alzheimer's Disease Pathology
    Hoozemans, J. J. M.
    Veerhuis, R.
    Rozemuller, J. M.
    Eikelenboom, P.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2011, 10 (01) : 57 - 67
12345